Sibannac, Inc. (SNNC) Financial Statements (2024 and earlier)

Company Profile

Business Address 2122 E. HIGHLAND AVENUE, SUITE 425
PHOENIX, AZ 85016
State of Incorp. NV
Fiscal Year End August 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

2/28/2017
MRQ
8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 92746341
Cash and cash equivalents 92746341
Receivables 601   
Inventory, net of allowances, customer advances and progress billings    20118
Inventory    20118
Other current assets 4   
Other undisclosed current assets    2211
Total current assets: 732756346130
Noncurrent Assets
Property, plant and equipment    2641
Intangible assets, net (including goodwill) 11940 
Intangible assets, net (excluding goodwill) 11940   
Other undisclosed noncurrent assets 131250 13010
Total noncurrent assets: 250290 15651
TOTAL ASSETS: 32356563202181
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 542372240 
Interest and dividends payable 2020   
Employee-related liabilities  22  
Other undisclosed accounts payable and accrued liabilities 33 70240 
Debt 234234   
Due to related parties 7    
Other undisclosed current liabilities 71    
Total current liabilities: 36625772240 
Noncurrent Liabilities
Liabilities, other than long-term debt 250250   
Accounts payable and accrued liabilities 250250   
Total noncurrent liabilities: 250250   
Other undisclosed liabilities   65413464
Total liabilities: 616507138653464
Equity
Equity, attributable to parent, including: (293)58(75)(451)(284)
Common stock 1818255
Common stock, value, subscriptions   63
Additional paid in capital 4141791131131
Accumulated deficit (351) (868)(587)(420)
Other undisclosed equity, attributable to parent   (63)  
Total equity: (293)58(75)(451)(284)
TOTAL LIABILITIES AND EQUITY: 32356563202181

Income Statement (P&L) ($ in thousands)

2/28/2017
TTM
8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
Revenues 524  207288
Cost of revenue
(Cost of Goods and Services Sold)
 (453)  (170)(196)
Other undisclosed gross profit    147135
Gross profit: 70  184227
Operating expenses (270)(2,375)(70)(329)(449)
Other undisclosed operating income  2,241   
Operating loss: (199)(133)(70)(145)(221)
Nonoperating expense
(Other Nonoperating expense)
 (152)    
Interest and debt expense (31)  (22)13
Loss from continuing operations: (382)(133)(70)(168)(208)
Income (loss) before gain (loss) on sale of properties: (382)524(281)(168)(208)
Income (loss) from discontinued operations  657(211)  
Other undisclosed net loss  (2,899)   
Net loss: (382)(2,375)(281)(168)(208)
Other undisclosed net income (loss) attributable to parent 310  (26)
Net loss available to common stockholders, diluted: (351)(2,374)(281)(168)(234)

Comprehensive Income ($ in thousands)

2/28/2017
TTM
8/31/2016
8/31/2015
8/31/2014
8/31/2013
8/31/2012
Net loss: (382)(2,375)(281)(168)(208)
Comprehensive loss, net of tax, attributable to parent: (382)(2,375)(281)(168)(208)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: